These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19648384)

  • 21. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
    Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
    JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
    Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
    J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: A retrospective US claims study.
    Duh MS; Roberts MH; Rothnie KJ; Cheng WY; Thompson-Leduc P; Zhang S; Czira A; Slade D; Greatsinger A; Zhang A; Mapel D
    Respir Med; 2024 May; 226():107629. PubMed ID: 38593885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions to improve adherence to inhaled steroids for asthma.
    Normansell R; Kew KM; Stovold E
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012226. PubMed ID: 28417456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE; Hagiwara M; Stanford RH; Stempel DA
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reasons and outcomes for patients receiving ICS/LABA agents prior to, and one month after, emergency department presentations for acute asthma.
    Villa-Roel C; Borgundvaag B; Majumdar SR; Emond M; Campbell S; Sivilotti M; Abu-Laban RB; Stiell IG; Aaron SD; Senthilselvan A; Rowe BH;
    J Asthma; 2019 Sep; 56(9):985-994. PubMed ID: 30311821
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β
    Pavord ID; Mathieson N; Scowcroft A; Pedersini R; Isherwood G; Price D
    NPJ Prim Care Respir Med; 2017 Mar; 27(1):17. PubMed ID: 28270657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S; Forget A; Beauchesne MF; Blais L
    J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and economic impact of a one-year treatment with omalizumab in patients with severe allergic asthma within a drug programme in Poland.
    Jahnz-Różyk K; Lis J; Warchoł M; Kucharczyk A
    BMC Pulm Med; 2018 Mar; 18(1):48. PubMed ID: 29548318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ratio of controller to total asthma medications: determinants of the measure.
    Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
    Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled corticosteroid use and outcomes in pregnancy.
    Schatz M; Leibman C
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):234-8. PubMed ID: 16200813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States.
    Averell CM; Laliberté F; Germain G; Duh MS; Rousculp MD; MacKnight SD; Slade DJ
    Ther Adv Respir Dis; 2022; 16():17534666221116997. PubMed ID: 36036456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.
    Wilson EC; Price D; Musgrave SD; Sims EJ; Shepstone L; Murdoch J; Mugford HM; Blyth A; Juniper EF; Ayres JG; Wolfe S; Freeman D; Gilbert RF; Hillyer EV; Harvey I
    Pharmacoeconomics; 2010; 28(7):597-608. PubMed ID: 20446755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inadequate follow-up controller medications among patients with asthma who visit the emergency department.
    Cydulka RK; Tamayo-Sarver JH; Wolf C; Herrick E; Gress S
    Ann Emerg Med; 2005 Oct; 46(4):316-22. PubMed ID: 16187464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation.
    Rhee CK; van Boven JFM; Yau Ming SW; Park HY; Kim DK; Park HS; Ling JZJ; Yoo KH; Price DB
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):934-942. PubMed ID: 30292924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
    Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
    J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
    Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
    J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial.
    Wilson EC; Sims EJ; Musgrave SD; Shepstone L; Blyth A; Murdoch J; Mugford HM; Juniper EF; Ayres JG; Wolfe S; Freeman D; Gilbert RF; Harvey I; Hillyer EV; Price D
    Pharmacoeconomics; 2010; 28(7):585-95. PubMed ID: 20550224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study.
    Thomas M; Murray-Thomas T; Fan T; Williams T; Taylor S
    BMC Pulm Med; 2010 May; 10():29. PubMed ID: 20470409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.